In collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), TFFP Pharmaceuticals Inc (NASDAQ: TFFP) has reported positive preclinical in vitro efficacy ...
TFF Pharmaceuticals Inc (TFFP) stock has reached a new 52-week low, trading at $0.4, as investors respond to ongoing market pressures. This latest price point marks a significant downturn for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results